Cargando…

Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction

BACKGROUND: Prediction of left ventricular (LV) remodeling after acute myocardial infarction (MI) is clinically important and would benefit from the discovery of new biomarkers. METHODS: Blood samples were obtained upon admission in patients with acute ST-elevation MI who underwent primary percutane...

Descripción completa

Detalles Bibliográficos
Autores principales: Devaux, Yvan, Bousquenaud, Melanie, Rodius, Sophie, Marie, Pierre-Yves, Maskali, Fatiha, Zhang, Lu, Azuaje, Francisco, Wagner, Daniel R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240818/
https://www.ncbi.nlm.nih.gov/pubmed/22136666
http://dx.doi.org/10.1186/1755-8794-4-83
_version_ 1782219478559358976
author Devaux, Yvan
Bousquenaud, Melanie
Rodius, Sophie
Marie, Pierre-Yves
Maskali, Fatiha
Zhang, Lu
Azuaje, Francisco
Wagner, Daniel R
author_facet Devaux, Yvan
Bousquenaud, Melanie
Rodius, Sophie
Marie, Pierre-Yves
Maskali, Fatiha
Zhang, Lu
Azuaje, Francisco
Wagner, Daniel R
author_sort Devaux, Yvan
collection PubMed
description BACKGROUND: Prediction of left ventricular (LV) remodeling after acute myocardial infarction (MI) is clinically important and would benefit from the discovery of new biomarkers. METHODS: Blood samples were obtained upon admission in patients with acute ST-elevation MI who underwent primary percutaneous coronary intervention. Messenger RNA was extracted from whole blood cells. LV function was evaluated by echocardiography at 4-months. RESULTS: In a test cohort of 32 MI patients, integrated analysis of microarrays with a network of protein-protein interactions identified subgroups of genes which predicted LV dysfunction (ejection fraction ≤ 40%) with areas under the receiver operating characteristic curve (AUC) above 0.80. Candidate genes included transforming growth factor beta receptor 1 (TGFBR1). In a validation cohort of 115 MI patients, TGBFR1 was up-regulated in patients with LV dysfunction (P < 0.001) and was associated with LV function at 4-months (P = 0.003). TGFBR1 predicted LV function with an AUC of 0.72, while peak levels of troponin T (TnT) provided an AUC of 0.64. Adding TGFBR1 to the prediction of TnT resulted in a net reclassification index of 8.2%. When added to a mixed clinical model including age, gender and time to reperfusion, TGFBR1 reclassified 17.7% of misclassified patients. TGFB1, the ligand of TGFBR1, was also up-regulated in patients with LV dysfunction (P = 0.004), was associated with LV function (P = 0.006), and provided an AUC of 0.66. In the rat MI model induced by permanent coronary ligation, the TGFB1-TGFBR1 axis was activated in the heart and correlated with the extent of remodeling at 2 months. CONCLUSIONS: We identified TGFBR1 as a new candidate prognostic biomarker after acute MI.
format Online
Article
Text
id pubmed-3240818
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32408182011-12-17 Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction Devaux, Yvan Bousquenaud, Melanie Rodius, Sophie Marie, Pierre-Yves Maskali, Fatiha Zhang, Lu Azuaje, Francisco Wagner, Daniel R BMC Med Genomics Research Article BACKGROUND: Prediction of left ventricular (LV) remodeling after acute myocardial infarction (MI) is clinically important and would benefit from the discovery of new biomarkers. METHODS: Blood samples were obtained upon admission in patients with acute ST-elevation MI who underwent primary percutaneous coronary intervention. Messenger RNA was extracted from whole blood cells. LV function was evaluated by echocardiography at 4-months. RESULTS: In a test cohort of 32 MI patients, integrated analysis of microarrays with a network of protein-protein interactions identified subgroups of genes which predicted LV dysfunction (ejection fraction ≤ 40%) with areas under the receiver operating characteristic curve (AUC) above 0.80. Candidate genes included transforming growth factor beta receptor 1 (TGFBR1). In a validation cohort of 115 MI patients, TGBFR1 was up-regulated in patients with LV dysfunction (P < 0.001) and was associated with LV function at 4-months (P = 0.003). TGFBR1 predicted LV function with an AUC of 0.72, while peak levels of troponin T (TnT) provided an AUC of 0.64. Adding TGFBR1 to the prediction of TnT resulted in a net reclassification index of 8.2%. When added to a mixed clinical model including age, gender and time to reperfusion, TGFBR1 reclassified 17.7% of misclassified patients. TGFB1, the ligand of TGFBR1, was also up-regulated in patients with LV dysfunction (P = 0.004), was associated with LV function (P = 0.006), and provided an AUC of 0.66. In the rat MI model induced by permanent coronary ligation, the TGFB1-TGFBR1 axis was activated in the heart and correlated with the extent of remodeling at 2 months. CONCLUSIONS: We identified TGFBR1 as a new candidate prognostic biomarker after acute MI. BioMed Central 2011-12-05 /pmc/articles/PMC3240818/ /pubmed/22136666 http://dx.doi.org/10.1186/1755-8794-4-83 Text en Copyright ©2011 Devaux et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Devaux, Yvan
Bousquenaud, Melanie
Rodius, Sophie
Marie, Pierre-Yves
Maskali, Fatiha
Zhang, Lu
Azuaje, Francisco
Wagner, Daniel R
Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction
title Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction
title_full Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction
title_fullStr Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction
title_full_unstemmed Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction
title_short Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction
title_sort transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240818/
https://www.ncbi.nlm.nih.gov/pubmed/22136666
http://dx.doi.org/10.1186/1755-8794-4-83
work_keys_str_mv AT devauxyvan transforminggrowthfactorbreceptor1isanewcandidateprognosticbiomarkerafteracutemyocardialinfarction
AT bousquenaudmelanie transforminggrowthfactorbreceptor1isanewcandidateprognosticbiomarkerafteracutemyocardialinfarction
AT rodiussophie transforminggrowthfactorbreceptor1isanewcandidateprognosticbiomarkerafteracutemyocardialinfarction
AT mariepierreyves transforminggrowthfactorbreceptor1isanewcandidateprognosticbiomarkerafteracutemyocardialinfarction
AT maskalifatiha transforminggrowthfactorbreceptor1isanewcandidateprognosticbiomarkerafteracutemyocardialinfarction
AT zhanglu transforminggrowthfactorbreceptor1isanewcandidateprognosticbiomarkerafteracutemyocardialinfarction
AT azuajefrancisco transforminggrowthfactorbreceptor1isanewcandidateprognosticbiomarkerafteracutemyocardialinfarction
AT wagnerdanielr transforminggrowthfactorbreceptor1isanewcandidateprognosticbiomarkerafteracutemyocardialinfarction